Compare Crispr Therapeutics AG (CRSP) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Western Digital Corp — how do they compare? Crispr Therapeutics AG trades at $53.39 (market cap $4.88B), while Western Digital Corp trades at $397.28 (market cap $147.23B). The key difference: Western Digital Corp is far larger — about 30.2× Crispr Therapeutics AG's market cap, and Western Digital Corp pays a 0.15% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crispr Therapeutics AG for 77 Days and Western Digital Corp for 37 Days on average.
| CRSP | WDC | |
|---|---|---|
Market Cap | $4.88B | $147.23B |
Volume | 2,861,747 | 9,341,468 |
Sector | Health | Technology |
52-Week High | $74.92 | $746.23 |
52-Week Low | $44.34 | $113.13 |
Typical Hold Time | 77 Days | 37 Days |
Enterprise Value | $3.30B | $146.70B |
Dividend Yield | — | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRISPR Therapeutics (CRSP) trades at $50.44, down 3.65% amid bearish technical signals. The company shows negative profitability with -$581.60M net income and -4,101.26% net margin for 2025, though Q2 2026 EPS beat expectations. Positive analyst sentiment persists with 57.9% buy ratings and $67.83 consensus target. Recent clinical data presentations and CASGEVY commercial progress provide catalysts.
The stock faces fundamental challenges with persistent losses and negative cash flow from operations, but maintains Wall Street support for its gene-editing pipeline. Key risks include clinical trial outcomes and cash burn, while potential upside hinges on successful drug commercialization and upcoming data readouts through 2026.
Western Digital (WDC) trades at $393.31, down 2.94% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and impressive profitability metrics including 71.97% net income margin and 131.02% ROE. Technical indicators signal bearish momentum with the price below key resistance levels, while analyst consensus remains overwhelmingly bullish with a $647.58 price target representing 65% upside potential.
WDC presents a compelling investment case with robust AI-driven storage demand and strong financial performance, though near-term headwinds from competitive pressures and technical weakness warrant caution. The company's dominant market position and margin expansion potential support long-term growth, but investors should monitor Toshiba's competitive moves and quarterly execution against elevated expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
